Our work indicates that mTOR-VEGF pathway is hyperactivated in SXNI induced pseudo-allergic reactions, and rapamycin might be a potentially drug to prevent SXNI mediated pseudo-allergic reactions. This evidence concerns the gene VEGFA and allergic disease.